Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Encompass Health Corporation is a medical care facilities business based in the US. Encompass Health Corporation shares (EHC) are listed on the NYSE and all prices are listed in US Dollars. Encompass Health Corporation employs 43,800 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Guided investing
Our top pick for
Building a portfolio
Our top pick for
Beginners
| Latest market close | $61.63 |
|---|---|
| 52-week range | $56.07 - $88.66 |
| 50-day moving average | $63.36 |
| 200-day moving average | $75.31 |
| Wall St. target price | $84.67 |
| PE ratio | 16.2137 |
| Dividend yield | $1.12 (1.7%) |
| Earnings per share (TTM) | $4.06 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $61.63 from 2022-01-18
| 1 week (2022-01-12) | -3.07% |
|---|---|
| 1 month (2021-12-16) | -2.30% |
| 3 months (2021-10-19) | -9.07% |
| 6 months (2021-07-19) | -21.00% |
| 1 year (2021-01-19) | -25.89% |
|---|---|
| 2 years (2020-01-17) | -22.44% |
| 3 years (2019-01-18) | 66.48 |
| 5 years (2017-01-19) | 54.27% |
Valuing Encompass Health Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Encompass Health Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Encompass Health Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 16x. In other words, Encompass Health Corporation shares trade at around 16x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Encompass Health Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.1 billion.
The EBITDA is a measure of a Encompass Health Corporation's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $5 billion |
|---|---|
| Operating margin TTM | 16.33% |
| Gross profit TTM | $1.8 billion |
| Return on assets TTM | 7.68% |
| Return on equity TTM | 24.32% |
| Profit margin | 8.1% |
| Book value | $18.52 |
| Market capitalisation | $6.6 billion |
TTM: trailing 12 months
Dividend payout ratio: 26.79% of net profits
Recently Encompass Health Corporation has paid out, on average, around 26.79% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.7% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Encompass Health Corporation shareholders could enjoy a 1.7% return on their shares, in the form of dividend payments. In Encompass Health Corporation's case, that would currently equate to about $1.12 per share.
While Encompass Health Corporation's payout ratio might seem fairly standard, it's worth remembering that Encompass Health Corporation may be investing much of the rest of its net profits in future growth.
Encompass Health Corporation's most recent dividend payout was on 17 January 2022. The latest dividend was paid out to all shareholders who bought their shares by 30 December 2021 (the "ex-dividend date").
Encompass Health Corporation's shares were split on a 1:5 basis on 25 October 2006. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Encompass Health Corporation shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for Encompass Health Corporation shares which in turn could have impacted Encompass Health Corporation's share price.
Over the last 12 months, Encompass Health Corporation's shares have ranged in value from as little as $56.0712 up to $88.6567. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Encompass Health Corporation's is 1.0309. This would suggest that Encompass Health Corporation's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families to address patients' physical needs, including pain control and symptom management, and to provide emotional and spiritual support. As of December 14, 2021, it operated 145 hospitals, 249 home health locations, and 95 hospice locations in 42 states and Puerto Rico.
Donut earns up to 10% APY, but you must have an iOS device.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
Everything we know about the Austin Gold IPO, plus information on how to buy in.
Everything we know about the VinFast IPO, plus information on how to buy in.
Creating a golf club is a thus-far unique application of NFTs, and another step forward for the decentralized economy.
Everything we know about the Nexalin Technology IPO, plus information on how to buy in.
Everything we know about the Specialty Building Products IPO, plus information on how to buy in.
Everything we know about the HeartCore Enterprises IPO, plus information on how to buy in.